Previous Page  56 / 218 Next Page
Information
Show Menu
Previous Page 56 / 218 Next Page
Page Background

54

Chapter 3

et al., 1995), State-Trait Anxiety Inventory (STAI; (Spielberger et al., 1970)), and Listening

span (Daneman and Carpenter, 1980; Salthouse et al., 1991) (

supplementary materials and

methods

). Verbal IQ was determined using Dutch Adult Reading Test, (DART) the Dutch

version of the National Adult Reading Test (Schmand et al., 1991).

Genotyping

All molecular genetic analyses were carried out in a CCKL-certified laboratory at the

department of Human Genetics of the Radboud University Nijmegen Medical Centre. DNA

was isolated from saliva samples using Oragene kits (DNA Genotek Inc, Ottawa, Ontario,

Canada). Genotyping of the 40 base pair variable number of tandem repeats (VNTR)

polymorphism in the 3’ untranslated region of the

SLC6A3/DAT1

gene encoding the DAT

was performed as follows. Genomic DNA (100 ng) was amplified with 0.2 µM fluorescently

labelled forward primer (5’-Ned-TGTGGTGTAGGGACGGCCTGAGAG-3’) and 0.2 µM

reverse primer (5’-CTTCCTGGAGGTCACGGCTCAAGG-3’) with PIG tail, 0.25 mM

dNTPs, 0.4 U AmpliTaq Gold DNA polymerase (Applied Biosystems, Nieuwerkerk a/d

Ijssel, The Netherlands) in an PCR Optimized buffer D, (Invitrogen, Breda, The Netherlands)

containing 10% DMSO (v/v). Cycling conditions were 12 min 95 °C followed by 35 cycles

of 1 min 94°C, 1 min 58°C and 1 min 72°C, and a final 5 min at 72°C. PCR products were

diluted 10 times and 1 µl of the diluted PCR product together with 9.7 µl formamide and 0.3 µl

GeneScan-600 Liz Size StandardTM (Applied Biosystems) was analyzed on an 3730 Genetic

Analyzer (Applied Biosystems) according to the protocol of the manufacturer. Analysis of

the length of the PCR products was performed with Genemapper software. To investigate the

random genotyping error rate, the lab included 5% duplicate DNA samples, which had to be

100% consistent. In addition, 4% blanks were included, which were required to be negative.

Most of the participants (except three) took part in the study before their genotype was

determined. After their participation, three groups of genotypes were established: a group

homozygous for the common 10-repeat allele (10R/10R) (

n

= 27, mean age: 21.7 + 2.2, 12

female), a group homozygous for the 9-repeat allele (9R/9R) (

n

= 7), and a group of 9R/10R

heterozygotes (

n

= 14). The 9R/9R and 9R/10R subjects were combined into one group of 9R

carriers (

n =

21, mean age: 21.4 + 1.9, 12 female). Three 10R homozygotes of this sample were

selected from an existing genetic database at the centre. Of the subgroup of participants who

received four instead of two drug sessions, we only included data from the 10R homozygotes

(

n

= 14; mean age: 21.9 + 2.4, 6 females), because these were the participants showing an effect

of bromocriptine in the larger sample.

The DAT removes dopamine from the synapse into the pre-synaptic neuron (Willeit and

Praschak-Rieder, 2010), thereby terminating its action. The 10-repeat allele has been

associated with increased gene expression and presumably lower levels of synaptic dopamine

in the striatum relative to the 9-repeat allele (e.g., Heinz et al., 2000; Fuke et al., 2001; Mill et

al., 2002; VanNess et al., 2005) (but see van Dyck et al., 2005).